Gaia Biomed
Fukuoka, JP · 3 known investors
GAIA BioMedicine (株式会社ガイアバイオメディシン) develops GAIA-NK, a cell therapy using engineered cells with high cytotoxic activity against solid tumors, based on research from Kyushu University. The company researches, develops, and manufactures regenerative medicine products aimed at curative cancer treatment.
BiotechHealthtechMedical Devices
Founders & leadership
YY
Yoshikazu YonemitsuFounder
KK
Kazuyuki KuramoriRepresentative Director, President & CEO
YH
Yui HaradaDirector & CTO
DA
Daisuke AraDirector & CFO